(Press-News.org) Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people’s own immune system T cells to fight cancer.
The findings were published Oct. 3 in the journal JCI-Insight.
“Maximizing the effectiveness of T-cell-based therapies remains a critical challenge,” says David Kass, M.D., Abraham and Virginia Weiss Professor of Cardiology at the Johns Hopkins University School of Medicine and senior author of the study. “We’ve identified a powerful way to boost T cell function, offering a promising avenue for improving cancer immunotherapy and potentially treating a wide range of infectious and other diseases.”
Kass and his team emphasize that their experiments to date are preclinical, and will require significant further laboratory-based efforts before they can be applied to human therapies.
For the current study, Kass and his team focused on CD8+ T cells, the circulating immune system “soldiers” responsible for identifying and fighting infections and cancer cells.
A protein called TSC2 (tuberous sclerosis protein 2) can activate or block a molecular pathway that regulates the T cells.
Overall, their experiments show that introducing a mutation in the TSC2 gene acts as a molecular “volume knob” to dial up or down the T cells’ regulatory pathway when it’s actively responding to immune challenges such as a virus or a cancer antigen. Like a volume knob, there is no change until the music starts — then it is louder. The researchers found the mutated T cells were acting no differently than normal ones when they were just resting and not being stimulated to attack a target. They only became more active when stimulated. This type of control is relatively new for T cells.
This discovery, Kass says, raises the possibility of enhancing a therapy known as CAR-T, in which T cells are genetically engineered to better recognize a particular cancer. If these T cells also had the mutation in the TSC2 gene, the T cells could be more active against the tumor by multiplying, but could also persist longer, enhancing the T cells’ effectiveness to kill cancer.
The scientists also found that the T cells containing the TSC2 mutation could expand in great numbers during the initial immune response, but then could also persist long-term, which differs greatly from other T cells used for therapy.
The T cells with the TSC2 mutation were also better able to multiply and be activated to fight infections and to counter tumors, despite being in an environment that was more acidic or had lower oxygen than their nonmutated counterparts.
“After testing our modified T cells, we found they were better at stopping tumor growth, proliferated more inside the tumor and didn’t get tired out as easily,” Kass says. “As we continue to unravel the complexities of the immune system, such innovative approaches hold promise for revolutionizing the field of immunotherapy.”
In recent years, dozens of immunotherapies with novel drugs and antibodies have come on the market to treat cancer and other diseases, but response rates in patients vary widely, and overall, their optimal effectiveness as a group is only in the 15%–20% range. There is room for improvement, and many ongoing efforts are underway to do this. The new results may ultimately contribute to those efforts.
The researchers plan to do further studies with solid tumors such as lung, liver and colon cancers, which, compared with blood tumors such as leukemia, have been harder to achieve complete success with T cell-based therapies.
Additional authors of the study include Chirag Patel, the primary researcher for the work, and Jonathan Powell, both formerly with the Bloomberg~Kimmel Institute for Immunotherapy and now with Calico Life Sciences LLC; Yi Dong, Xiaoxu Wang and Jiayu Wen with the Bloomberg~Kimmel Institute for Immunotherapy; Navid Koleini, Brittany Dunkerly-Eyring and Mark Ranek with the Johns Hopkins University School of Medicine Division of Cardiology; and Laura Bartle, Daniel Henderson and Jason Sagert with CRISPR Therapeutics.
Patel, Dunkerly-Eyring, Ranek, Kass and Powell have filed a patent for the use of TSC2 mutations at Serine 1364 and Serine 1365 (human) to treat disease.
This study was supported by the National Institutes of Health and the Bloomberg Kimmel Institute for Cancer Immunotherapy.
Researchers report protein mutation creates ‘super’ T cells with potential to fight off cancer and infections
T cells that carry specific mutation have potential to improve cancer immunotherapy
ELSE PRESS RELEASES FROM THIS DATE:
Enhancing the efficiency of plant regeneration
Crop modification can be traced to the beginning of agriculture and human civilization. Native Americans, for example, developed corn from a wild grass called teosinte more than 7,000 years ago. Methods to increase crop resiliency and sustainability have evolved, and improved, over time. Biotechnology, or the use of biology to develop new products and organisms, is an application that holds great promise for impactful changes to the agricultural systems. Through this method, the DNA in plant cells is modified — for instance ...
Registration now open for Energy Department’s National Science Bowl®
Washington, D.C. – Registration is open for the 34th National Science Bowl® (NSB), hosted by the U.S. Department of Energy (DOE) Office of Science. Thousands of students compete in the contest annually as it has grown into one of the largest academic math and science competitions in the country. Teams – four or five students and a teacher who serves as a coach – can sign up to participate in the NSB by registering with the coordinator for their regional competition. Details can be found on the NSB registration page. The competition is divided into two categories: high school and middle school. Regional competitions typically last one or two days ...
Disaster-proofing sustainable neighborhoods requires thorough long-term planning, new Concordia study shows
Individual neighbourhoods will be intimately involved in providing local solutions to collective problems. One measure will be distributed renewable energy production — energy produced at local levels, either by solar technology, wind or other methods, will push cities to achieve their net-zero targets. However, even these power-generating neighbourhoods will remain vulnerable to power outages resulting from natural disasters such as hurricanes, fires or floods. And all of these are likely to become increasingly common due to the effects of climate change. ...
Carbon-capture tree plantations threaten tropical biodiversity for little gain, ecologists say
The increasingly urgent climate crisis has led to a boom in commercial tree plantations in an attempt to offset excess carbon emissions. However, authors of a peer-reviewed opinion paper publishing October 3 in the journal Trends in Ecology and Evolution argue that these carbon-offset plantations might come with costs for biodiversity and other ecosystem functions. Instead, the authors say we should prioritize conserving and restoring intact ecosystems. “Despite the broad range of ecosystem functions and services provided ...
Can science take the STING out of runaway inflammation?
CINCINNATI—Until the COVID-19 pandemic exploded, few people outside of research labs and intensive care units had heard of a cytokine storm. But once this dangerous form of infection-triggered runaway inflammation started claiming lives by the thousands, a legion of scientists jumped into the hunt for ways to calm these storms. Now, a study led by immunobiology experts at Cincinnati Children’s, offers important new details on how two elements of our body’s immune system clash with each other to prompt a chain of reactions that can release deadly floods of cell-killing, organ-damaging ...
Adherence to CPAP treatment and the risk of recurrent cardiovascular events
About The Study: The results of this meta-analysis indicate that adherence to continuous positive airway pressure (CPAP) was associated with a reduced major adverse cardiac and cerebrovascular event recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with obstructive sleep apnea. Authors: Ferran Barbé, M.D., of the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) in Madrid, is the corresponding author. To access the ...
Spending on mental health services for kids and adolescents has risen by more than 25% since beginning of pandemic
Spending on mental health services for children and adolescents has risen by more than one-quarter since the beginning of the COVID-19 pandemic, continuing to rise even as the use of telehealth plateaued, according to a new RAND Corporation study. Spending on mental health for people aged 19 and younger rose by 26% from March 2020 to August 2022 among a large group whose families have employer-provided insurance. During the same period, use of mental health services increased by 22%. The study found that use of telehealth for pediatric patients increased more than 30-fold during the early months of the pandemic and remained ...
Surgical scorecards may cut cost of surgical procedures without impacting outcomes
Key takeaways A tool for evaluating the overall cost of a surgical procedure, called a scorecard, helps reduce costs of surgical procedures between 5% and 20% without adversely affecting clinical outcomes. Further implementation of scorecards may move surgeons toward energy-efficient operating rooms, which are the largest hospital producer of emissions and waste. CHICAGO (October 3, 2023): Surgical scorecards, a tool that gives direct feedback ...
Utilization and spending on mental health services among children and youths with commercial insurance
About The Study: After comparing mental health care service utilization and spending rates for children and youths with commercial insurance across three periods from January 2019 through August 2022, this study found differences between periods as well as different rates of change within each period for both visit types (in-person and telehealth), even after accounting for state and patient sex. Utilization and spending increased over the entire timeframe. Attention-deficit/hyperactivity disorder, anxiety disorders, and adjustment disorder accounted for most visits and spending in all phases. Authors: Mariah ...
Psychotropic medication use in children and adolescents with type 1 diabetes
About The Study: This study found an increasing trend in psychotropic medication dispensation among Swedish children and adolescents with type 1 diabetes from 2006 to 2019, persistently higher than those without type 1 diabetes. These findings call for further in-depth investigations into the benefits and risks of psychotropic medications within this population and highlight the importance of integrating pediatric diabetes care and mental health care for early detection of psychological needs and careful monitoring of medication use. Authors: Shengxin ...
LAST 30 PRESS RELEASES:
ASH: Novel combination therapy significantly reduces spleen volume in patients with myelofibrosis
ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias
ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder
New Sylvester cancer study provides insight into underlying gene mutations in myelodysplastic syndromes
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
Mindfulness could help women with opioid use disorder better control drug urges
TTUHSC’s ARPA-H membership will spur innovation, improve access for West Texas patients
Global annual finance flows of $7 trillion fueling climate, biodiversity, and land degradation crises
Tracing how the infant brain responds to touch with near-infrared spectroscopy
These are the world's most effective charities
When is an aurora not an aurora?
Advisory panel issues field-defining recommendations for US government investments in particle physics research
Doctors discover many patients at UNC’s Inflammatory Bowel Disease Clinic screen positive for malnutrition
BNL: Advisory panel issues field-defining recommendations for U.S. government investments in particle physics research
International collaboration uses faculty member’s research on ancient Roman migration, seeks to understand Balkan genomic history
USF Health Heart Institute doctors are upbeat about cardiac regeneration
AI-driven breakthroughs in cells study: SFU-UBC collaboration introduces "MCS-detect" for advancements in super-resolution microscopy
Advisory panel issues field-defining recommendations for investments in particle physics research
$3.8 million NIH grant to fund Southwest Center on Resilience for Climate Change and Health
What happens when the brain loses a hub?
Study reveals Zika’s shape-shifting machinery—and a possible vulnerability
RIT leading STEM co-mentoring network
Genetic mutations that promote reproduction tend to shorten human lifespan, study shows
CAMH develops potential new drug treatment for multiple sclerosis
Polyethylene waste could be a thing of the past
A dynamic picture of how we respond to high or low oxygen levels
University of Toronto researchers discover new lipid nanoparticle that shows muscle-specific mRNA delivery, reduces off-target effects.
Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
Finding the most heat-resistant substances ever made[Press-News.org] Researchers report protein mutation creates ‘super’ T cells with potential to fight off cancer and infections
T cells that carry specific mutation have potential to improve cancer immunotherapy